Location History:
- Leicestershire, GB (2012 - 2013)
- Cheshire, GB (2014)
Company Filing History:
Years Active: 2012-2014
Title: Neal Michael Smith: Innovator in Chemokine Receptor Modulation
Introduction
Neal Michael Smith is a distinguished inventor based in Leicestershire, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of chemokine receptor modulators. With a total of three patents to his name, Smith's work is pivotal in addressing chemokine-mediated diseases and disorders.
Latest Patents
Smith's latest patents include innovative compounds that are designed to act as chemokine receptor modulators. One of his notable patents describes pyrimidine sulphonamide derivatives, which are presented as a compound of formula (I), or a pharmaceutically acceptable salt, solvate, or in vivo hydrolysable ester thereof. These compounds are integral to pharmaceutical compositions aimed at treating various chemokine-mediated diseases and disorders.
Career Highlights
Neal Michael Smith is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to leverage his expertise in drug development and innovation. Smith's work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.
Collaborations
Throughout his career, Smith has collaborated with notable colleagues, including David R Cheshire and Rhona Jane Cox. These collaborations have fostered a productive environment for innovation and have contributed to the success of his research endeavors.
Conclusion
Neal Michael Smith is a prominent figure in the field of pharmaceutical innovation, with a focus on chemokine receptor modulation. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.